AIDP announces exclusive partnership with American River Nutrition
AIDP will be responsible for the sales and marketing efforts to promote the company’s GG-Gold and DuoQuinol ingredients from American River Nutrition.
Photo © iStockphoto.com/skynesher
AIDP (City of Industry, CA) has announced an exclusive partnership with American River Nutrition (Hadley, MA) in which AIDP will be responsible for the sales and marketing efforts to promote the company’s GG-Gold and DuoQuinol ingredients.
GG-Gold Geranylgeraniol (GG) is an endogenous nutrient in the body that is essential for skeletal muscle protein synthesis and the production of testosterone, progesterone, CoQ10 and MK4. Because GG declines with age, GG-Gold can help replenish natural levels of GG to reduce the risk of age-related physical decline. Duoquinol is a patented combination of ubiquinol and GG that creates a complementary mechanism that supports heart function and cellular energy with ubiquinol, while GG in the formula naturally stimulates CoQ10 production to promote muscle function and strength.
“We are very excited about this partnership as we have strong mutual interest in providing wider access to functional ingredients,” says Barrie Tan PhD, president of American River Nutrition, in a press release. “We look forward to providing strong technical support to AIDP.”
“We jumped on this opportunity to work with Barrie to sell these products from American River; we see them as key vectors for our continued growth in bringing scientifically-backed ingredients to market,” said Mark Thurston, president of AIDP.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
